Liang Lin

Stephen Lin, is a Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, he most recently worked as BD at GlaxoSmithKline (Great China), covering M&A and product licensing. Prior to that, he managed the marketing of a core product at Merck Serono (China). In Sanjiu Medical & Pharmaceutical, he set up and headed the Strategic Development Department. Stephen holds Master of Science in Medicinal Chemistry and Bachelor in Pharmaceutical Chemistry, both from China Pharmaceutical University, and an M.B.A. degree from China Europe International Business School. He is also a Licensed Pharmacist in China.